Anti-seizure drug promotion faces legal fire
Monday, February 22, 2010 - 20:21
in Mathematics & Economics
A lawsuit over the anti-seizure drug Neurontin began in the U.S. on Monday, with patients, insurance companies and unions accusing the drug manufacturer of aggressively marketing it as pain medication.